Phase I PK and Safety Study of Ondansetron Inhalation Powder

Clinical trial NCT07498751 · COMPLETED

Trial details

NCT number: NCT07498751
Sponsor: Luxena Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postoperative Nausea and Vomiting

Start date: 2025-03-13
Primary completion: 2025-08-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.